|
Magyar Osteológiai és Osteoarthrológiai Társaság |
|
Osteoporosis - helyünk Európában -- az Osteoporosis Betegek Magyarországi Egyesületének konferenciája a Civil Fórumon |
Rendezvény kezdete: 2005.05.25. | Rendezvény vége: 2005.05.25. |
Helyszín: VI. Magyar Osteologiai Kongresszus, Balatonfüred, Hotel Füred |
2005 . május 25. szerda
11.00- 12.30 - ig
Témák:
- Marton István: A Magyar Modell - Az OP Centrumok hálózat
nemzetközi elismertsége, Hogyan illeszkedik be a Magyar Modell a társaságok (hazai, nemzetközi ) rendszerébe
- Nagy Irén: Osteoporosis helyzete Romániában
- Bálint Géza: Statisztikai Adatok
- Bálint Géza:Költségek
- Somogyi Péter: Törések
- Barna Judit:NeTörj program, Bossányi Ada program
- Mező Tibor: Adatbázisok / Hazai Adatbábázis
- Szekeres László: Diagnosztikai eszközök
- Szekeres László: Terápiás lehetőségek
- Bors Katalin:Gondozás
- Szekeres László: Irányelvek
- Szekeres László / Marton István: Tennivalók
- Marton István / Bors Katalin:Csontritkulás és az öregedő társadalom
- Somogyi Péter: Töréssel kapcsolatos programok
- Szekeres lászló / Márton László: Társadalombiztosítás
- Olajos Péter: Osteoporosis Interest Group
The European Parliament Osteoporosis Interest Group is an informal, all-party group founded by a former MEP, Mrs Mel Read, in December 2001, to help stimulate much needed policy developments at both national and European levels. The International Osteoporosis is the secretariat for the Group.
Over the last three years members of the Interest Group have played an important role in increasing political awareness about osteoporosis both at European and national levels by participating in awareness activities and by supporting relevant legislation. Since the recent European Parliament elections the Interest Group has been reformed with Mary Honeyball MEP and Angelika Niebler MEP as co-chairs. The Group is committed to improving policies for osteoporosis by playing an active role in the Call for Action.
|
|
|
 |
|
Magyar Osteológiai és Osteoarthrológiai Társaság |
|
Osteoporosis - helyünk Európában -- az Osteoporosis Betegek Magyarországi Egyesületének konferenciája a Civil Fórumon |
Rendezvény kezdete: 2005.05.25. | Rendezvény vége: 2005.05.25. |
Helyszín: VI. Magyar Osteologiai Kongresszus, Balatonfüred, Hotel Füred |
2005 . május 25. szerda
11.00- 12.30 - ig
Témák:
- Marton István: A Magyar Modell - Az OP Centrumok hálózat
nemzetközi elismertsége, Hogyan illeszkedik be a Magyar Modell a társaságok (hazai, nemzetközi ) rendszerébe
- Nagy Irén: Osteoporosis helyzete Romániában
- Bálint Géza: Statisztikai Adatok
- Bálint Géza:Költségek
- Somogyi Péter: Törések
- Barna Judit:NeTörj program, Bossányi Ada program
- Mező Tibor: Adatbázisok / Hazai Adatbábázis
- Szekeres László: Diagnosztikai eszközök
- Szekeres László: Terápiás lehetőségek
- Bors Katalin:Gondozás
- Szekeres László: Irányelvek
- Szekeres László / Marton István: Tennivalók
- Marton István / Bors Katalin:Csontritkulás és az öregedő társadalom
- Somogyi Péter: Töréssel kapcsolatos programok
- Szekeres lászló / Márton László: Társadalombiztosítás
- Olajos Péter: Osteoporosis Interest Group
The European Parliament Osteoporosis Interest Group is an informal, all-party group founded by a former MEP, Mrs Mel Read, in December 2001, to help stimulate much needed policy developments at both national and European levels. The International Osteoporosis is the secretariat for the Group.
Over the last three years members of the Interest Group have played an important role in increasing political awareness about osteoporosis both at European and national levels by participating in awareness activities and by supporting relevant legislation. Since the recent European Parliament elections the Interest Group has been reformed with Mary Honeyball MEP and Angelika Niebler MEP as co-chairs. The Group is committed to improving policies for osteoporosis by playing an active role in the Call for Action.
|
|
|
 |
|
Magyar Immunológiai Társaság |
|
DC2012 - 12th International Symposium on Dendritic Cells |
Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
Munkahely neve: DC 2012 Secretariat |
Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
Tel: +82-2-577-8422,8423 |
Fax: +82-2-566-6087 |
E-mail: dc@people-x.com |
Helyszín: Korea, Daegu, EXCO Convention Center |
A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
 |
|
Magyar Immunológiai Társaság |
|
DC2012 - 12th International Symposium on Dendritic Cells |
Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
Munkahely neve: DC 2012 Secretariat |
Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
Tel: +82-2-577-8422,8423 |
Fax: +82-2-566-6087 |
E-mail: dc@people-x.com |
Helyszín: Korea, Daegu, EXCO Convention Center |
A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
 |